From a Student Competition to a Potential Treatment for Celiac Disease

Synthetic DNA Approach is Key to Startup’s New Drug

By Lisa Howard

The way Justin Siegel describes it, ordering synthetic DNA is almost as easy as ordering a pair of shoes online.

“You just type it in — or if the protein has been sequenced at one point, we can copy and paste — order it, and it shows up five days later.”

UC Davis chemist Justin Siegel is a co-founder of PvP Biologics. The company is developing a new treatment for celiac disease, an autoimmune disorder triggered by ingesting gluten. (UC Davis/Karin Higgins)